ASMB (Assembly Biosciences, Inc.) Quarterly EPS earnings growth

Assembly Biosciences (ASMB) - corporate logo

The quarterly EPS growth rate helps assess the management efficiency of Assembly Biosciences (ASMB) and the transparency of its partnership with Gilead. The team has pivoted its strategy toward developing long-acting antivirals, sharing risks with industry behemoths. The implementation of robotic systems is accelerating the discovery of new molecules. The value of 84.90 represents the final metric reading, demonstrating the ultimate trajectory of the company's operating income dynamics.

assemblybio.com (ASMB) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/10/2026

Summary analytical data breakdowns for Assembly Corp (ASMB)

- share price and consensus valuation forecast:
Stock Quotes Assembly Biosciences, Inc.|ASMB - Price Target Chart
- business market valuation indicators:
Market Capitalization Assembly Biosciences Inc|ASMB - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Assembly Biosciences|ASMB - Accounting Value of Company|Market Capitalization to Book Value Ratio assemblybio.com|ASMB - Company Total Assets
- company liabilities and liquidity data:
Debt to Equity Assembly Biosciences|ASMB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Assembly Biosciences|ASMB - Company Total Debt Obligations|Debts to Book Capitalization Assembly Biosciences Inc|ASMB - Long-Term Debt|Company Short-Term Debt Assembly Biosciences|Quick Ratio assemblybio.com
- earnings and market multiples details:
ASMB - Company Net Income|Expected Profit Assembly Biosciences|ASMB - Price to Earnings Ratio|Projected Price to Earnings Assembly Biosciences Inc|ASMB - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Assembly Biosciences Inc|ASMB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Assembly Biosciences|ASMB - Earnings per share for the last twelve months|Quarterly EPS earnings growth assemblybio.com|ASMB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Assembly Biosciences
Analysis of all company metrics:Assembly Biosciences, Inc. - ASMB
Manufactured product of Assembly Biosciences

A comparative asset analysis requires precise measurement of net income growth rates. This metric captures the quarterly earnings per share (EPS) trend, isolating the fundamental trajectory from market noise. For Assembly Biosciences (ASMB), this indicator reflects the success of clinical developments independent of macroeconomic cycles. Investors should assess business sustainability through quarterly EPS growth.

Analysis of competing companies

ARWR (Arrowhead Pharmaceuticals, Inc.) - Year-over-year net earnings per share growth for the last 12 months|MIRM (Mirum Pharmaceuticals, Inc.) - Year-over-year earnings per share growth for the last twelve months|DVAX (Dynavax Technologies) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tekmira Pharmaceuticals ABUS|Year-over-year earnings per share growth for the last twelve months Inventiva S.A. (IVA)|GYRE (gyretx.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth GALT (Galectin Therapeutics Inc.)|Quarterly EPS earnings growth Genfit SA GNFT|DRRX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Aligos Therapeutics ALGS|biovieinc.com (BIVI) - Year-over-year earnings per share growth for the last twelve months|GLMD - Year-over-year net earnings per share change for the last twelve months|NDRA (ENDRA Life Sciences Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Hepion Pharma HEPA